VBI Vaccines
VBIV
#10650
Rank
A$2.71 M
Marketcap
A$0.09461
Share price
0.00%
Change (1 day)
-90.19%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): A-$15.27

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is A-$14.69. In 2022 the company made an earnings per share (EPS) of A-$19.12 a decrease over its 2021 EPS that were of A-$11.74.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$15.27
2022A-$19.1262.96%
2021A-$11.7428.57%
2020A-$9.13-54.35%
2019A-$19.99-52.58%
2018A-$42.1610.23%
2017A-$38.2514.29%
2016A-$33.47-62.8%
2015A-$89.9790.68%
2014A-$47.19-7.95%
2013A-$51.26-57.97%
2012A-$121.98-78%
2011A-$554.543151.47%
2010A-$17.0623.87%
2009A-$13.77-18.48%
2008A-$16.8912.08%
2007A-$15.07-49.47%
2006A-$29.83
2005N/A-100%
2004A-$13.2611.94%
2003A-$11.85-81.89%
2002A-$65.41196.44%
2001A-$22.0684.33%
2000A-$11.97-65.37%
1999A-$34.56-29.45%
1998A-$48.9929.61%
1997A-$37.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.38-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A-$5.32-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.27-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA